According to a recent review of the literature, LINC01871 has been identified by several studies in breast cancer through bioinformatic measurement involving the cellular phenotype of autophagy (Li et al., 2021; Wu et al., 2021; Jiang et al., 2022; Luo et al., 2022), stemness (Li et al., 2020), immune response (Ma et al., 2020; Mathias et al., 2021), ferroptosis (Xu et al., 2021), and lipid metabolism (Shi et al., 2022). Here, LINC01871 is linked to breast cancer.